Key Points: COVID In today’s Recommendation for Industry, we discuss the positive trajectories of COVID and monkeypox. Read more below. COVID-19 may have orphaned 7.5
Key Points: COVID In today’s Recommendation for Industry, we discuss the typical increase of respiratory disease in the fall and how to prepare now. Read
Key Points: COVID In today’s Recommendation for Industry, we discuss the alternating status of monkeypox and Covid. Read more below. FDA authorizes updated COVID boosters
Key Points: COVID In today’s Recommendation for Industry, we discuss 2022-23 U.S. Seasonal Influenza Vaccine Overview. Read more below. Paxlovid, molnupiravir benefit older COVID-19 patients,
Key Points: COVID In today’s Recommendation for Industry, we discuss the continued trend of Monkeypox and Covid. Read more below. Regular physical activity tied to
Key Points: COVID In today’s Recommendation for Industry, we discuss flu season in the Southern Hemisphere. Read more below. Serious adverse events rare after COVID-19
TAG Expands Assessments to Include Current Communicable Disease Data Key Points: COVID In today’s Recommendation for Industry, we discuss TAG expanding our public health offerings
Key Points: In today’s Recommendation for Industry, we discuss the “why” behind testing at Day 6 if you’ve been exposed and testing multiple times for
Key Points: In today’s Recommendation for Industry, we discuss the positive COVID trends we are seeing. Read more below. Study: Pfizer COVID vaccine efficacy wanes
